Global Gastric Cancer Market Report: 2016 Edition - New Reports by Koncept Analytics

DELHI, India - June 2, 2016 - PRLog -- Cancer is a condition where normal cells of the body exhibit abnormal cell growth. A cancer cell continues living while a normal cell would die, thus accumulating to form a tumor that can break off and spread throughout the body. Gastric cancer is stomach cancer that most commonly occurs in the mucus-producing cells on the inside lining of the stomach.

The causes of gastric cancer include a diet high in smoked, salted and pickled foods, obesity and ageing. Medical study has also found a high correlation between H.Pylori infection and gastric cancer. An individual with gastric cancer may experience symptoms like fatigue, feeling bloated after eating, severe heartburn and indigestion, stomach pain, persistent and unexplained vomiting and nausea, unintentional weight loss, belching, anemia, and persistent ulcer. Gastric Cancer can be medically diagnosed through upper endoscopy, imaging tests and exploratory surgery, while treatment options include surgery, chemotherapy, radiotherapy and targeted therapy.

Global gastric cancer market is conspicuous by poor prognosis, because symptoms of the disease are such that it has usually advanced by the time it is diagnosed. However, medical advances like better diagnostic technology and shifting treatment market from chemotherapy to targeted therapies is expected to warrant positive growth in the years ahead. Factors driving the market include, rising spending on targeted cancer therapies, ageing population, increasing obese population, rising cigarette consumption, inclining global male population and rising oncology drug spending.

The report provides an overview of the entire gastric cancer market through global and regional analysis. Prevalence and market value of gastric cancer across the globe and that of its various types and stages including advanced, her2 positive, stage III and metastatic gastric cancer have been analyzed. Certain trends like healthy pipeline of combination targeted therapies, shifting focus towards molecular targeted therapies, and keen interest in eradication of H. Pylori infection across the globe have been discussed along with the challenges that the market faces in low penetration of new targeted therapies and lack of reimbursement of cancer drugs.

List of Charts

Different Types of Gastric Cancer
Global Gastric Cancer Market by Prevalence (2015-2020E)
Global Advanced Gastric Cancer Market by Value (2015-2020E)
The U.S. Gastric Cancer Market by Prevalence (2015-2020E)
Prevalence of Her 2+ Gastric Cancer in the U.S. (2015-2020E)
Prevalence of Stage III Gastric Cancer in the U.S. (2015-2020E)
The U.S. Advanced Gastric Cancer Market by Prevalence (2015-2020E)
The U.S. Advanced Gastric Cancer Market by Value (2015-2020E)
Prevalence of Metastatic Gastric Cancer in the U.S. (2015-2020E)
Prevalence of Her2+ Gastric Cancer in the EU (2015-2020E)
Prevalence of Stage III Gastric Cancer in the EU (2015-2020E)
Prevalence of Metastatic Gastric Cancer in the EU (2015-2020E)
The EU5 Gastric Cancer Market by Prevalence (2015-2020E)
The EU5 Advanced Gastric Cancer Market by Prevalence (2015-2020E)
The EU5 Advanced Gastric Cancer Market by Value (2015-2020E)
Japan Gastric Cancer Market by Prevalence (2015E-2020E)
Japan Advanced Gastric Cancer by Prevalence (2015-2020E)
Japan Advanced Gastric Cancer Market by Value (2015-2020E)
Global Targeted Therapies Spending (2010-2015E)
Global Oncology Drug Spending by Region (2010-2015E)
Global Population Over 50 Years of Age (2010-2015E)
Global Obese Population (2010-2015E)
Global Male Population (2010-2015E)
Global Cigarettes Consumption (1910-2014)
Combination Regimen Launches in Oncology (2014-2020E)
Pipeline of Targeted Agents in Development by Pathways (2015)
Penetration of New Targeted Therapies by Country (2015)
Cancer Drugs Reimbursement Status by Country (2015E)
Potential Combination Therapy Launches by Company (2021E)
Gastric Cancer - Top Companies Revenue Comparison (2015)
Gastric Cancer - Revenue Growth Comparison by Company (2015)
Roche Holdings AG Revenue by Segment (2015)
Roche Holdings AG Revenue and Net Income (2011-2015)
Bristol Myers Revenue by Region (2015)
BMY Revenue and Net Income (2011-2015)
Merck & Co. Inc. Revenue by Segment (2015)
Merck & Co. Inc. Revenue and Net Income (2011-2015)
AstraZeneca Revenue by Region (2015)
AstraZeneca Revenue and Net Income (2011-2015)

List of Tables

Types of Targeted Therapies
Top Cancer Drugs by Revenue (2015)
Gastric Cancer Pre-Treated Clinical Trials Comparison
Gastric Cancer Treatment Naive Clinical Trials

Note:  Purchase by Section Also Available

For more Information:

http://www.konceptanalytics.com/Researchreport/global-gastric-cancer-market-report-2016-edition-9277.aspx

Koncept Analytics

Vikas Gupta

(Business Development Manager)

FFCS-36, Ansal Plaza

Vaishali, Ghaziabad

U.P - 201010

Tele: +91-120-4130959

Mobile: +91-9811715635

Mail ID - vikas@konceptanalytics.com

Koncept Analytics is a market research company. We are in the field of Market Research from last 10 Years. We do research in telecommunication, healthcare, pharmaceutical, financial services, energy, technology, real estate, logistics, food & beverages and media sectors. For more information:

http://www.konceptanalytics.com